Penumbra PEN - オプションチェーン | ADVFN

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Penumbra Inc (PEN)
Penumbra Inc (PEN) オプション

Penumbra Inc (PEN)

277.69

-8.69

(-3.03%)

終了 3月7日 6:00AM

277.69

0.00

(0.00%)

取引時間後: 7:30AM

PEN ライブオプションフロー

オプションコール

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	81.00	85.90	0.00	83.45	0.00	0.00 %	0	0	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
210.00	66.20	70.10	0.00	68.15	0.00	0.00 %	0	0	-
220.00	56.50	60.20	0.00	58.35	0.00	0.00 %	0	0	-
230.00	46.60	50.50	0.00	48.55	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	27.60	31.40	25.08	29.50	0.00	0.00 %	0	1	-
260.00	19.00	22.60	44.20	20.80	0.00	0.00 %	0	2	-
270.00	12.40	15.30	20.40	13.85	0.00	0.00 %	0	7	-
280.00	6.60	8.70	13.00	7.65	0.00	0.00 %	0	160	-
290.00	2.95	5.20	7.90	4.075	0.00	0.00 %	0	2,524	-
300.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
310.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	0.05	1.65	0.56	0.85	0.00	0.00 %	0	2,487	-
340.00	1.85	1.70	1.85	1.775	0.00	0.00 %	0	400	-
350.00	0.00	2.25	0.00	0.00	0.00	0.00 %	0	0	-
360.00	0.00	1.75	0.00	0.00	0.00	0.00 %	0	0	-
370.00	0.00	0.95	0.00	0.00	0.00	0.00 %	0	0	-

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

オプションプット

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
190.00	0.00	2.15	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.00	2.15	0.00	0.00	0.00	0.00 %	0	0	-
200.00	1.12	2.20	1.12	1.66	0.00	0.00 %	0	2	-
210.00	0.00	2.25	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	1.50	4.40	2.00	2.95	0.00	0.00 %	0	11	-
270.00	4.30	6.00	5.50	5.15	0.00	0.00 %	0	25	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	14.40	17.10	10.40	15.75	0.00	0.00 %	0	37	-
300.00	22.40	25.40	16.70	23.90	0.00	0.00 %	0	15	-
310.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
320.00	40.70	44.50	0.00	42.60	0.00	0.00 %	0	0	-
330.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
340.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
350.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
360.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
370.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PSTVPlus Therapeutics Inc	US$ 1.46 (317.14%)	357.55M
AGMHAGM Group Holdings Inc	US$ 0.213 (108.21%)	690.72M
LZMHLZ Technology Holdings Ltd	US$ 9.79 (33.56%)	576.65k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 14.62 (33.39%)	15.92M
GVVisionary Holdings Inc	US$ 4.89 (32.34%)	134.05M
BLNEEastside Distilling Inc	US$ 0.7846 (-89.40%)	12.01k
ACONAclarion Inc	US$ 1.5501 (-77.86%)	51.24M
ELABPMGC Holdings Inc	US$ 0.7132 (-42.02%)	1.48M
SNBRSleep Number Corporation	US$ 7.49 (-41.89%)	4.52M
CCLDCareCloud Inc	US$ 2.0904 (-33.00%)	1.22M
AGMHAGM Group Holdings Inc	US$ 0.213 (108.21%)	690.72M
PSTVPlus Therapeutics Inc	US$ 1.46 (317.14%)	357.55M
NVDANVIDIA Corporation	US$ 110.57 (-5.74%)	314.56M
GVVisionary Holdings Inc	US$ 4.89 (32.34%)	134.05M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10.75 (-11.38%)	131.89M

@LaughinPaulRyan

@LaughinPaulRyan 4年前

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 4年前

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 4年前

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 4年前

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 4年前

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 10年前

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 10年前

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 10年前

IPO should be out soon.
no symbol yet.

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約